Reimagine your clinical genomic interpretation with same day, expert variant classification services tailored to your oncology panel
The promise of cancer precision medicine hinges on one key concept: target the right disease with the right treatment for the right patient at the right time.
But getting everything right is easier said than done. Today, pathologists face enormous time pressure and have to examine a staggering amount of information to make treatment decisions, for every single cancer patient. QCI Precision Insights simplifies the process. A professional clinical interpretation service that translates molecular data specific to each patient into clinical insights and therapeutic options, QCI Precision Insights delivers the evidence you need within minutes.
With QCI Precision Insights, you can reduce test turnaround time by 85-90%—regardless of panel size.
Powered by a world-class team of molecular biologists and oncologists, QCI Precision Insights delivers concise clinical evidence for each biomarker in the context of the cancer sub-type, listing information on the mutation’s molecular characteristics, roles in disease, and therapeutic, prognostic, and diagnostic implications.
You receive a ready to use expert-assembled report content with detailed assessments of variants, written summaries of evidence with references, treatments, and geographically matched clinical trials.
Submit your variant list to QCI Precision Insights and receive customized, oncologist-reviewed, variant-specific content within minutes.
Deliver reports with expert summaries of the latest biological, diagnostic, prognostic, and therapeutic evidence in context of the tumor profile, treatment, and regional clinical trials.
For rare or novel variants, enlist QIAGEN’s expert MD and PhD variant scientist team to perform the in-depth research, curation and interpretation for you.
In this application note, we discuss the importance of streamlined clinical NGS workflows within the hematologic-oncology space. Learn how to develop a robust, automated, and streamlined NGS analysis pipeline for the interpretation and reporting of genomic alterations associated with hematological malignancies.
To accelerate test turnaround times and ensure accurate reporting, Quest Diagnostics uses QCI Precision Insights to provide expert interpretation for their LeukoVantage assay, a NGS test for hematologic malignancies. Find out how QCI Precision Insights delivers reports that include diagnostic and prognostic information, therapeutic options, and clinical trials based on the unique combination of genomic alterations detected in each case and WHO, NCCN, and ELN guidelines.
Request a free, no-obligation consultation with a QCI Precision Insights expert to learn more about the service. Start sending us your clinical NGS data today.
Clinical decision support software enabling faster test turnaround times and higher confidence reporting for any indication on your sequencing platform
Leverage the benefits of automation and expert support to improve test turnaround times and clinical reporting capabilities
Solve more cases faster, with data you can trust using HGMD Professional, the de facto standard resource for identifying inherited disease-causing mutations